+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Central Nervous System Disorder Drugs Markets in China

  • PDF Icon

    Report

  • 214 Pages
  • November 2023
  • Region: China
  • AMID Co
  • ID: 1081214

China's demand for Central Nervous System Disorder Drugs will continue to grow at 12% by 2032

China's demand for Central Nervous System Disorder Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2012, 2017 and 2022) and long-term forecasts through 2027 and 2032 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and the in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

This market research report provides hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, this research report provides the insights and projections into Chinese markets necessary for you to do so.

Table of Contents

I. INTRODUCTION
  • Report Scope and Methodology
  • Executive Summary
II. BUSINESS ENVIRONMENT
  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties
III. CENTRAL NERVOUS SYSTEM DISORDER DRUGS INDUSTRY ASSESSMENTS
  • Central Nervous System Disorder Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Central Nervous System Disorder Drugs Sales Volume
  • Major Producer Facility Locations
  • Major Producers’ Sales Volume and Market Share
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investment
  • Technology Development
IV. CENTRAL NERVOUS SYSTEM DISORDER DRUGS PRODUCTION AND DEMAND
  • Central Nervous System Disorder Disease Overview
  • Central Nervous System Disorder Drugs Market Overview
  • Central Nervous System Disorder Drugs Market Overview by Classification
  • Antianxiety Drugs
  • Antidepressants
  • Antipsychotics
  • Anticonvulsants
  • Alzheimer's Disease Drugs
  • ADHD Drugs
  • Parkinson's Disease Drugs
  • Other Drugs
  • Central Nervous System Disorder Drugs Import and Export by Classification
  • Market Overview by Drug’s Active Principle
  • Market Overview by Producers
  • Pricing Trend
V. CENTRAL NERVOUS SYSTEM DISORDER DRUGS MARKET OUTLOOK
  • Central Nervous System Disorder Drugs Markets Outlook Overview
  • Government Regulation
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits
VI. MARKETING STRATEGIES
  • China Market Entry Overview
  • China's Distribution System
  • Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China’s Market Entry
  • Licensing
  • Franchising
  • E-commerce
  • Trading Companies and Local Agents
  • Representative Offices and Chinese Subsidiaries
  • Wholly Foreign Owned Enterprises
VII. CENTRAL NERVOUS SYSTEM DISORDER DRUGS PRODUCER DIRECTORY
  • Profiles of Central Nervous System Disorder Drugs Producers
LIST OF TABLES
I. INTRODUCTION
  • Economic Outlook Summary
II. BUSINESS ENVIRONMENT
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade
III. CENTRAL NERVOUS SYSTEM DISORDER DRUGS INDUSTRY ASSESSMENTS
  • Top 10 Central Nervous System Disorder Drugs Sales Volume and Market Share
  • Central Nervous System Disorder Drugs Sales Volume
  • Major Producer Facility Location
  • Major Central Nervous System Disorder Drugs Producer Sales Volume
  • Major Foreign Investment in China
IV. CENTRAL NERVOUS SYSTEM DISORDER DRUGS PRODUCTION AND DEMAND
  • Central Nervous System Disorder Drugs Sales Volume by Classification
  • Central Nervous System Disorder Drugs Import by Drugs Classification
  • Central Nervous System Disorder Drugs Export by Drugs Classification
  • Top 10 Central Nervous System Disorder Drugs Sales Volume and Their Market Share
  • Central Nervous System Disorder Drugs Major Producer, Sales Volume, and Market Share
V. CENTRAL NERVOUS SYSTEM DISORDER DRUGS MARKET OUTLOOK
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits
LIST OF CHARTS
I. INTRODUCTION
  • Central Nervous System Disorder Drugs Sales Volume
II. BUSINESS ENVIRONMENT
  • China’s GDP and Growth Rate
  • Industrial Output by Ownership
  • China’s Imports and Exports
III. CENTRAL NERVOUS SYSTEM DISORDER DRUGS INDUSTRY ASSESSMENTS
  • Central Nervous System Disorder Drugs Sales Volume
  • Central Nervous System Disorder Drugs Market Share by Drugs Classification
  • Top 10 Central Nervous System Disorder Drugs Market Share
  • Central Nervous System Disorder Drugs Sales Volume
IV. CENTRAL NERVOUS SYSTEM DISORDER DRUGS PRODUCTION AND DEMAND
  • Central Nervous System Disorder Drugs Sales Volume
  • Central Nervous System Disorder Drugs Sales Volume by Classification
  • Central Nervous System Disorder Drugs Import
  • Central Nervous System Disorder Drugs Export
  • Central Nervous System Disorder Drugs Market Share by Classification
  • Antianxiety Drugs Sales Volume and Market Share
  • Antidepressants Sales Volume and Market Share
  • Antipsychotic Sales Volume and Market Share
  • Anticonvulsants Sales Volume and Market Share
  • Alzheimer's Disease Drugs Sales Volume and Market Share
  • ADHD Drugs Sales Volume and Market Share
  • Parkinson's Disease Drugs Sales Volume and Market Share
  • Other Central Nervous System Disorder Drugs Sales Volume and Market Share
  • Central Nervous System Disorder Drugs Import by Drugs Classification
  • Antianxiety Drugs Import Volume and Market Share
  • Antidepressants Import Volume and Market Share
  • Antipsychotics Import Volume and Market Share
  • Anticonvulsants Import Volume and Market Share
  • Alzheimer's Disease Drugs Import Volume and Market Share
  • ADHD Drugs Import Volume and Market Share
  • Parkinson's Disease Drugs Import Volume and Market Share
  • Other Central Nervous System Disorder Drugs Import Volume and Market Share
  • Central Nervous System Disorder Drugs Export Volume by Drugs Classification
  • Antianxiety Drugs Export Volume and Market Share
  • Antidepressants Drugs Export Volume and Market Share
  • Antipsychotics Export Volume and Market Share
  • Anticonvulsants Export Volume and Market Share
  • Alzheimer's Disease Drugs Export Volume and Market Share
  • ADHD Drugs Export Volume and Market Share
  • Parkinson's Disease Drugs Export Volume and Market Share
  • Other Central Nervous System Disorder Drugs Export Volume and Market Share
V. CENTRAL NERVOUS SYSTEM DISORDER DRUGS MARKET OUTLOOK
VI. MARKETING STRATEGIES
  • China’s Distribution Channel

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AstraZeneca China
  • Lilly Pharmaceutical China Inc